Barclays’s Alignment Healthcare ALHC Stock Holding History
Bought
Maintained
Sold
Other funds holding ALHC
Barclays's ALHC Position: Q2 2026 in Review
Barclays increased its Alignment Healthcare (ALHC) stake by 58% in Q2 2026, buying an estimated $741K and bringing the position to 105,081 shares worth $2.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2223.
Barclays first reported a position in ALHC in Q1 2022 and has held it in 18 quarters since. The position peaked at $31M in Q2 2025. 324 funds tracked by Wall St. Rank hold ALHC as of Q2 2026.
- Barclays held 105,081 shares of Alignment Healthcare worth $2.5M as of Q2 2026.
- Barclays bought 38,605 Alignment Healthcare shares in Q2 2026, an estimated $741K.
- Alignment Healthcare made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #2223 holding.
- Barclays first reported a position in Alignment Healthcare in Q1 2022 and has held it in 18 quarters since.
- Barclays's Alignment Healthcare position peaked at $31M in Q2 2025.
- 324 funds tracked by Wall St. Rank held Alignment Healthcare as of Q2 2026.
Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.